News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Veronica R Bravo: The Role of Off-pore Nucleoporins in Prostate Cancer Progression and Immune Evasion
Veronica R Bravo/mayo.edu
Aug 2, 2025, 15:10

Veronica R Bravo: The Role of Off-pore Nucleoporins in Prostate Cancer Progression and Immune Evasion

Veronica R Bravo, Associate Professor at Mayo Clinic, shared a post on X by Elizabeth McKenna, Executive Editor of Cancer Discovery, adding:

“Very excited about our last paper in Cancer Discovery on the role of off-pore nucleoporins in prostate cancer progression and immune evasion.

An adventure into the nucleus with the best team.

Shout out to 1st authors Kirthika, Vijay, and Peiyao.”

Quoting Elizabeth McKenna‘s post:

“Now in Cancer Discovery:

Off-Pore Nucleoporin sPOM121 Propels β-Catenin-Driven Tumor Progression and Immune Escape in Prostate Cancer – by Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, Zhu Lab, Veronica R Bravo, Josep Domingo-Domenech et al..”

Veronica R Bravo

Title: Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancer

Journal: Cancer Discovery

Authors: Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, Michael Xu, Marc Carceles-Cordon, Adam Ertel, S. Aidan Quinn, Daniel P. Petrylak, Jacob J. Orme, Scott M. Dehm, Emmanuel S. Antonarakis, Elisabeth I. Heath, Mukesh K. Pandey, Carlos Cordon-Cardo, Haojie Huang, Haidong Dong, Shijia Zhu, Josep Domingo-Domenech, Veronica Rodriguez-Bravo

Read the full article.

Veronica R Bravo

More posts featuring prostate cancer on OncoDaily.

Adam Ertel cancer Cancer Discovery Carlos Cordon-Cardo Daniel P. Petrylak Elisabeth I. Heath Elizabeth McKenna Emmanuel S Antonarakis Haidong Dong Haojie Huang Jacob J. Orme Josep Domingo-Domenech Marc Carceles-Cordon Mayo Clinic Michael Xu Mukesh K. Pandey off-pore nucleoporins OncoDaily Oncology Peiyao Li Perumalraja Kirthika prostate cancer S. Aidan Quinn Scott M. Dehm Shijia Zhu Veronica R Bravo Veronica Rodriguez-Bravo Vijayakumar Jawalagatti Zhu Lab
Special Coverage
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts
Radiotherapy
Aug 21, 2025, 12:31
New RT Paper Alert: Novel NOVEMBER Trial Puts 9-Day Breast Cancer Radiation Schedule to the Test
Opinion
Aug 21, 2025, 12:03
UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support
Voices
Aug 21, 2025, 11:40
FDA has Granted Full Market Approval for Papzimeos - NIH